Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_assertion type Assertion NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_head.
- NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_assertion description "[Although GLP-1 receptor (GLP-1R) agonists are under development for the treatment of diabetes, GLP-1 administration may increase blood pressure and heart rate in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_provenance.
- NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_assertion evidence source_evidence_predicted NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_provenance.
- NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_assertion SIO_000772 12093887 NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_provenance.
- NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_assertion wasDerivedFrom rgd-20150221 NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_provenance.
- NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_assertion wasGeneratedBy ECO_0000218 NP43682.RAmgnvnJk8kz-mKvvzDAyKMWfScBLFYMEHThFZ6h14I8E130_provenance.